Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2016-06-08 15:54:42 |
Versijas komentārs | |
Teksts |
Olainfarm holds First Quarter 2016 Investor Conference Webinar
AS „Olainfarm” invites shareholders, investors, mass media
representatives and other stakeholders to join its investor
conference webinar scheduled today at 16:00 (EET).
To join the
webinar please follow the instructions
below.
Webinar will be hosted by the Member of the Management Board Salvis
Lapiņš. The presentation will be held in
English.
During the webinar Salvis Lapiņš will inform about AS “Olainfarm”
latest activities, provide more detailed information about the
recent acquisition - company “Tonus Elast” and analyze the
financial results of the first quarter 2016. During the webinar the
attached presentation will be presented.
What is
webinar?
How to join the
webinar?
To join the webinar,
we invite you to register via
ej.uz/OLF_Q1_2016.
You will be provided
with the webinar link and instructions to join webinar
successfully. When joining the webinar for the first time, you will
be asked to download the system application on your computer which
will take only few seconds. For
more information on webinar service please visit:
http://www.nasdaqbaltic.com/en/products-services/webinars-3/
JSC Olainfarm is
one of the biggest pharmaceutical companies in Latvia with more
than 40 years of experience in production of medication and
chemical and pharmaceutical products. A basic principle of
company's operations is to produce reliable and effective top
quality products for Latvia and the rest of the world. Products
made by the Group are being exported to more than 35 countries of
the world, including the Baltics, Russia, other CIS, Europe, Asia,
North America and Australia. Information
prepared by: |
Pielikumi |